These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 28488973)
1. A pathogen reduction clinical trial in retrospect. Rebulla P Blood Transfus; 2017 Jul; 15(4):329-332. PubMed ID: 28488973 [No Abstract] [Full Text] [Related]
2. Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma. Liumbruno GM; Sodini ML; Grazzini G; Blood Transfus; 2008 Jan; 6(1):25-36. PubMed ID: 18661921 [No Abstract] [Full Text] [Related]
3. Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols. Arbaeen AF; Schubert P; Serrano K; Carter CJ; Culibrk B; Devine DV Transfusion; 2017 May; 57(5):1208-1217. PubMed ID: 28236302 [TBL] [Abstract][Full Text] [Related]
4. The six questions of pathogen reduction technology: an overview of current opinions. Solheim BG; Seghatchian J Transfus Apher Sci; 2008 Aug; 39(1):51-7. PubMed ID: 18614401 [TBL] [Abstract][Full Text] [Related]
5. Pathogen reduction technology. Rock G Transfus Apher Sci; 2008 Aug; 39(1):1. PubMed ID: 18619904 [No Abstract] [Full Text] [Related]
6. Current opinions on the role of pathogen reduction technology in improving the viral safety of blood and derivatives. Seghatchian J Transfus Apher Sci; 2008 Aug; 39(1):49-50. PubMed ID: 18617442 [No Abstract] [Full Text] [Related]
8. Current methods for the reduction of blood-borne pathogens: a comprehensive literature review. Picker SM Blood Transfus; 2013 Jul; 11(3):343-8. PubMed ID: 23522896 [No Abstract] [Full Text] [Related]
9. Massive transfusions for critical bleeding: is everything old new again? Flint AWJ; McQuilten ZK; Wood EM Transfus Med; 2018 Apr; 28(2):140-149. PubMed ID: 29607593 [TBL] [Abstract][Full Text] [Related]
11. Current status of cleaning and disinfection for gastrointestinal endoscopy in China: a survey of 122 endoscopy units. Zhang X; Kong J; Tang P; Wang S; Hyder Q; Sun G; Zhang R; Yang Y Dig Liver Dis; 2011 Apr; 43(4):305-8. PubMed ID: 21269894 [TBL] [Abstract][Full Text] [Related]
12. [Guide for transfusion of blood components]. Ortiz P; Mingo A; Lozano M; Vesga MA; Grifols JR; Castrillo A; Algora M; Romón I; Cárdenas JM; Med Clin (Barc); 2005 Sep; 125(10):389-96. PubMed ID: 16185550 [No Abstract] [Full Text] [Related]
14. Guidelines for administering blood and blood components. Gray S; Murphy M Nurs Stand; 1999 Dec 15-2000 Jan 4; 14(13-15):36-9. PubMed ID: 11209371 [TBL] [Abstract][Full Text] [Related]
15. Methylene blue and thionine in pathogen inactivation of plasma and platelet concentrates. Mohr H Transfus Apher Sci; 2001 Dec; 25(3):183-4. PubMed ID: 11846135 [No Abstract] [Full Text] [Related]
16. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice. Vamvakas EC Transfusion; 2013 Apr; 53(4):888-901. PubMed ID: 22882177 [TBL] [Abstract][Full Text] [Related]
17. Clinical appropriateness of blood component transfusion: regulatory requirements and standards set by the Scientific Society in Italy. Grazzini G Blood Transfus; 2008 Oct; 6(4):186-90. PubMed ID: 19112733 [No Abstract] [Full Text] [Related]
18. Current strategies for the provision of safer plasma and its derivatives: an update. Seghatchian J; Allain JP Transfus Apher Sci; 2001 Dec; 25(3):185-7. PubMed ID: 11846136 [No Abstract] [Full Text] [Related]